In development for UK general practice

Clinical intelligence. Connected to the work that matters.

Reedley is being built to read letters, results and prescription requests against the patient record, prepare the work each implies with its evidence, and leave every decision with clinicians.

In development · every demonstration uses synthetic data

Reedley · Documents

Synthetic patient
Margaret ASHWORTHNHS 999 000 0107Born 14 May 1947 · 79 y · Female
Margaret ASHWORTH NHS 999 000 0107

Born 14 May 1947 · 79 y · Female

Step 1 of 4 · A letter arrives

  1. A letter arrives
  2. Medication changes found
  3. Compared with the record
  4. Awaiting a clinician

Step 1 · A letter arrives

Cardiology clinic letter · Northfield General Hospital (fictional)

  • Dated 14 Sep 2026 · received 2 Oct 2026 15:40 via MESH (simulated)
  • Identity matched to the record: name, date of birth, NHS number
“Patient: Margaret ASHWORTH · born 14 May 1947 · NHS 999 000 0107”
Cardiology clinic letter header · dated 14 Sep 2026

Identifiedreceived is not reviewed

Step 2 · Medication changes found

Northfield General Hospital (fictional)

Blood pressure remains above target. I have increased ramipril from 5 mg to 10 mg once daily and increased bisoprolol from 2.5 mg to 5 mg once daily. Continue apixaban 5 mg twice daily.

  1. Medication changeramipril 5 mg → 10 mg once daily¶2
  2. Medication changebisoprolol 2.5 mg → 5 mg once daily¶2
  3. Informationapixaban: continue¶2

Step 3 · Compared with the record

The letter beside the medication record, 5 Oct 2026 08:03
MedicineLetterRecordResult
Ramipril10 mg once daily5 mg once dailyLetter and record differ
Bisoprolol5 mg once daily2.5 mg once dailyLetter and record differ
Apixaban5 mg twice daily (continue)5 mg twice dailyLetter and record match

Sources: Cardiology clinic letter ¶2 · dated 14 Sep 2026; medication record · as at 5 Oct 2026

Step 4 · Awaiting a clinician

Identified3 proposals · awaiting review by a clinician

  1. Medication record differs from the letter: ramipril, bisoprololPrescriber review requiredCardiology clinic letter ¶2 · dated 14 Sep 2026
  2. U&E within 2 weeks of the dose change · overdue by 7 daysDraft rule · clinical reviewCardiology clinic letter ¶3 · dated 14 Sep 2026 · Practice monitoring rule · draft · unsigned
  3. ramipril: prescriber review before reauthorisationPrescriber review requiredrepeat authorisation · as at 5 Oct 2026

Rests here. Nothing is accepted, assigned or changed until a named clinician reviews the evidence.

As of 5 Oct 2026 08:03. Reedley does not change the medication record. Every person and organisation shown is fictional.

In the development build · synthetic data · Scripted reconstruction: the development build itself is not running on this page.

Reedley · Documents

Synthetic patient
Margaret ASHWORTHNHS 999 000 0107Born 14 May 1947 · 79 y · Female

Step 1 of 3 · A letter arrives

  1. A letter arrives
  2. Compared with the record
  3. Awaiting a clinician

Step 1 · A letter arrives

Cardiology clinic letter · Northfield General Hospital (fictional)

  • Dated 14 Sep 2026 · received 2 Oct 2026 15:40 via MESH (simulated)
  • Identity matched to the record: name, date of birth, NHS number
“Patient: Margaret ASHWORTH · born 14 May 1947 · NHS 999 000 0107”
Cardiology clinic letter header · dated 14 Sep 2026

Identifiedreceived is not reviewed

Step 2 · Compared with the record

The letter beside the medication record, 5 Oct 2026 08:03
MedicineLetterRecordResult
RamiprilMedication change · ramipril 5 mg → 10 mg once daily · ¶210 mg once daily5 mg once dailyLetter and record differ
BisoprololMedication change · bisoprolol 2.5 mg → 5 mg once daily · ¶25 mg once daily2.5 mg once dailyLetter and record differ
ApixabanInformation · apixaban: continue · ¶25 mg twice daily (continue)5 mg twice dailyLetter and record match

Sources: Cardiology clinic letter ¶2 · dated 14 Sep 2026; medication record · as at 5 Oct 2026

Step 3 · Awaiting a clinician

Identified3 proposals · awaiting review by a clinician

  1. Medication record differs from the letter: ramipril, bisoprololPrescriber review requiredCardiology clinic letter ¶2 · dated 14 Sep 2026
  2. U&E within 2 weeks of the dose change · overdue by 7 daysDraft rule · clinical reviewCardiology clinic letter ¶3 · dated 14 Sep 2026 · Practice monitoring rule · draft · unsigned
  3. ramipril: prescriber review before reauthorisationPrescriber review requiredrepeat authorisation · as at 5 Oct 2026

Rests here. Nothing is accepted, assigned or changed until a named clinician reviews the evidence.

As of 5 Oct 2026 08:03. Reedley does not change the medication record. Every person and organisation shown is fictional.

In the development build · synthetic data · Scripted reconstruction: the development build itself is not running on this page.

The work today

Primary care work arrives in pieces.

A specialist letter, a medication list, an overdue blood test and a repeat request sit in different windows, and someone has to join them up.

The fragmented work

Synthetic patient
Margaret ASHWORTHNHS 999 000 0107Born 14 May 1947 · 79 y · Female
Margaret ASHWORTH NHS 999 000 0107

Born 14 May 1947 · 79 y · Female

Step 1 of 4 · Five places, one patient · Illustrative

  1. Five places, one patient Illustrative
  2. Brought into one workspace
  3. Connected clinical context
  4. Reviewable actions
Fragmented informationConnected clinical contextReviewable actions

Margaret ASHWORTH — after the cardiology letter of 14 Sep (received 2 Oct)

  1. Document inbox

    Specialist letter

    • Cardiology clinic letter · dated 14 Sep 2026 · received Fri 2 Oct 15:40
    “I have increased ramipril from 5 mg to 10 mg once daily and increased bisoprolol from 2.5 mg to 5 mg once daily.”

    Source Cardiology clinic letter ¶2 · dated 14 Sep 2026

  2. Clinical system (illustrative screen, no supplier shown)

    Medication list

    • Ramipril 5 mg once daily
    • Bisoprolol 2.5 mg once daily
    • Apixaban 5 mg twice daily
    • Atorvastatin 40 mg at night
    • Amlodipine 5 mg once daily
    • Metformin 500 mg twice daily

    Source medication record · as at 5 Oct 2026

  3. Repeat authorisations

    Pending review

    • Ramipril 5 mg capsules · 0 issues remaining · reauthorisation needs a prescriber

    Source repeat authorisation · as at 5 Oct 2026

  4. Results

    Missing monitoring result

    • Latest U&E 4 Sep 2026: potassium 4.8 mmol/L, eGFR 44 · no laboratory flag
    • Letter dated 14 Sep asks for U&E within 2 weeks of the dose change: no result on the record since 4 Sep

    Source Result · 4 Sep 2026 · Cardiology clinic letter ¶3 · dated 14 Sep 2026

  5. Requests

    Prescription request

    • Paper slip · received Fri 2 Oct 16:10
    • Bisoprolol 2.5 mg tablets, one daily

    Source Prescription request · received 2 Oct 2026 16:10

Also in context: consultation 28 Sep (Dr S. PATEL).
“Dizziness on standing since the hospital increased her blood pressure tablets. BP 108/62.”

Consultation · 28 Sep 2026 · Dr S. PATEL

one clinical review · 3 items, each with its own state

  1. Medication record differs from the letter: ramipril, bisoprololIdentifiedFor a prescriber
  2. U&E within 2 weeks of the dose change (ramipril) · overdue by 7 daysIdentifiedFor clinical review · draft rule
  3. ramipril: prescriber review before reauthorisationIdentifiedFor a prescriber

Linked request: bisoprolol 2.5 mg (paper)

The request’s dose differs from the letter’s 5 mg; it is shown beside the letter, not decided.

Synthetic data · scripted demonstration. Each step carries its own label: In the development build · synthetic data, or Illustrative demonstration · intended workflow. Every person and organisation shown is fictional.

In the development build · synthetic data, except steps marked Illustrative · Scripted reconstruction: the development build itself is not running on this page.

Fragments in. Context assembled. Actions reviewable.

Reedley is being built to gather what arrives, set it against the record and turn it into proposed actions a clinician can check against the evidence.

  1. Fragmented information

    One letter, one medication list, one pending authorisation, one missing result and one request, in five places.

    Illustrative demonstration · intended workflow
  2. Connected clinical context

    The same five things for one patient, side by side, each linked to its source.

    In the development build · synthetic data
  3. Reviewable actions

    Three proposals, each cited, waiting for a named clinician to accept, edit or reject.

    In the development build · synthetic data

The complete workflow

One letter, followed all the way through.

A document enters, context is assembled, changes are identified, the clinician reviews the evidence, a handover is prepared and the trail remains.

  • What entersA cardiology clinic letter for one synthetic patient.
  • What Reedley preparesContext, findings and proposals, each with its source; an illustrative handover draft.
  • What stays with the clinicianEvery decision. Nothing is sent, and the medication record is not changed.

The complete workflow

Synthetic patient

One cardiology letter followed from arrival to handover. Every person and organisation shown is fictional; the times are the synthetic record’s own, and the demonstration compresses them.

Margaret ASHWORTHNHS 999 000 0107Born 14 May 1947 · 79 y · Female
Margaret ASHWORTH NHS 999 000 0107

Born 14 May 1947 · 79 y · Female

One cardiology letter followed from arrival to handover. Every person and organisation shown is fictional; the times are the synthetic record’s own, and the demonstration compresses them.

Step 1 of 6 · A document enters

  1. A document enters
  2. Context assembled
  3. Changes and actions found
  4. Clinician reviews evidence
  5. Handover prepared Illustrative
  6. Work stays traceable

Step 1 · A document enters

Cardiology clinic letter received via MESH (simulated). Identity matched to the record. Received is not reviewed.

Received 2 Oct 2026 15:40 via MESH (simulated)

Patient: Margaret ASHWORTH · born 14 May 1947 · NHS 999 000 0107

Identifieddocument review

Step 2 · Context assembled

Record, results, the 28 Sep consultation and the paper request, beside the letter.

As at 5 Oct 2026

Ramipril 5mg capsules · 5 mg once daily

Northfield Pathology (fictional)

Potassium 4.8 mmol/L · eGFR 44 mL/min/1.73m² · no laboratory flag

Dr S. PATEL

Dizziness on standing since the hospital increased her blood pressure tablets. BP 108/62. Advised to monitor; awaiting clinic letter.

Received 2 Oct 2026 16:10

Repeat request (paper slip): bisoprolol 2.5 mg tablets, one daily.

Identifieddocument review

Step 3 · Changes and actions found

Two dose changes that differ from the record, a U&E request and a reauthorisation decision, each cited to ¶2 or ¶3.

Northfield General Hospital (fictional)

Blood pressure remains above target. I have increased ramipril from 5 mg to 10 mg once daily and increased bisoprolol from 2.5 mg to 5 mg once daily. Continue apixaban 5 mg twice daily.

Northfield General Hospital (fictional)

Please check urea and electrolytes within 2 weeks of the dose change. Echocardiogram arranged; review in 3 months.

  1. Medication record differs from the letter: ramipril, bisoprololDraft · not reviewed
  2. U&E within 2 weeks of the dose change (ramipril) · overdue by 7 daysDraft · not reviewed
  3. ramipril: prescriber review before reauthorisationDraft · not reviewed

Identifiedproposals

Step 4 · Clinician reviews evidence

K. AHMED reviews the letter with the record beside it and accepts the proposals. Three work items are created.

Document reviewReviewed by K. AHMED · 08:29

  1. Medication record differs from the letter: ramipril, bisoprololIdentifiedthis item
  2. U&E within 2 weeks of the dose change (ramipril) · overdue by 7 daysIdentified
  3. ramipril: prescriber review before reauthorisationIdentified

Step 5 · Handover prepared Illustrative

Assigned to Dr S. PATEL, due 6 Oct, with a handover note to copy into the practice’s own message.

Medication record differs from the letter: ramipril, bisoprololAssignedDr S. PATEL, GP · due 6 Oct
Illustrative

Copy-out only; nothing is written to any record. Copied text starts “DRAFT · SYNTHETIC DEMONSTRATION · NOT FOR CLINICAL USE”.

Copy-out only; Reedley sends nothing.

Step 6 · Work stays traceable

Every event is kept with who, when and the evidence. The item rests at assigned.

Medication record differs from the letter: ramipril, bisoprololDr S. PATEL, GP · due 6 Oct

  1. Identified5 Oct 08:29
  2. Reviewed5 Oct 08:36
  3. Assigned5 Oct 08:36
  4. Actionednot yet
  5. Verifiednot yet
  6. Closednot yet

Not verified: the medication record still shows ramipril 5 mg and bisoprolol 2.5 mg. Intended: verified when the record, re-read, shows the prescriber’s recorded decision (simulated here). A person’s report moves an item to actioned; verification comes from the record where Reedley can read it; where it cannot, a named person’s structured statement is accepted today, and that rule is under review.

  • U&E within 2 weeks of the dose change (ramipril) · overdue by 7 daysAssignedK. AHMED · due 7 Oct
  • ramipril: prescriber review before reauthorisationAssignedDr S. PATEL, GP · due 9 Oct

Event historyAppend-only by design · who, when, what

  1. · ReedleyLetter received; identity verified; document review identified.
  2. · ReedleyReview prepared: findings cited to ¶2 and ¶3; three proposals.
  3. · K. AHMEDLetter reviewed; proposals accepted; this item identified.
  4. · K. AHMEDItem reviewed and assigned to Dr S. PATEL, due 6 Oct; handover note prepared.

Synthetic data · scripted demonstration. Each step carries its own label: In the development build · synthetic data, or Illustrative demonstration · intended workflow. Source checks are simulated; Reedley does not change the medication record.

In the development build · synthetic data, except steps marked Illustrative · Scripted reconstruction: the development build itself is not running on this page.

Demonstrations

See Reedley in action.

Three flagship demonstrations on synthetic patients. Play, pause and step through each one here, then open it in full on its own page.

Ask Reedley

In the development build · synthetic data
Arrives
A question about one patient
Reedley prepares
An answer line by line, each line linked to its source
The clinician decides
You judge the answer against the sources
About Ask Reedley

Ask Reedley

Synthetic patient
Daniel OKONKWONHS 999 000 0115Born 02 Nov 1961 · 65 y · maleRecord as of 12 Nov 2026 09:40

Step 1 of 4 · Question asked

  1. Question asked
  2. Searching the record
  3. Findings with sources
  4. More questions Illustrative
Asked by K. AHMED, clinical pharmacist (prescriber)

When was the latest renal function result recorded?

Structured search of results

One answer, each line linked to the entries it rests on

The latest U&E was received in the record on 9 Nov 2026 at 15:20 (sample taken 9 Nov 08:50). As reported: creatinine 131 µmol/L, eGFR 52 mL/min/1.73m², no laboratory flag.

Uncertainty Shows when results arrived in the record and what the laboratory reported. Reedley does not interpret results or the change between them.

What was searched · 2 sources, 23 entries read, 4 cited
  • ResultsFound · 3 sourcesWaiting · 7 entries to readReading 7 entries7 entries read
  • Reedley work historyFound · 1 sourceWaiting · 16 entries to readReading 16 entries16 entries read
Record references · 5 entries, each passage marked

Record references

5 entries behind this answer · newest first · as of 12 Nov 2026 09:40

08:31 · Reedley, from the clinical record (Simulated)

Reviewed and filed by K. AHMED 12 Nov 2026 08:31. U&E item closed · completed.

15:20 · Reedley (Simulated)

U&E received in the record: the test happened; designed to stay open until a clinician’s review of this result is recorded (the development build closes on receipt).

Northfield Pathology (fictional) · received 9 Nov 2026 15:20

U&E: Na 140 mmol/L, K 4.6 mmol/L, creatinine 131 µmol/L, eGFR 52 mL/min/1.73m² · no laboratory flag

Northfield Pathology (fictional) · received 3 Jun 2026 15:48

U&E: Na 140 mmol/L, K 4.7 mmol/L, creatinine 124 µmol/L, eGFR 56 mL/min/1.73m² · no laboratory flag

Northfield Pathology (fictional) · received 14 Nov 2025 16:05

U&E: Na 141 mmol/L, K 4.5 mmol/L, creatinine 119 µmol/L, eGFR 59 mL/min/1.73m² · no laboratory flag

In the development build · synthetic data, except steps marked Illustrative · Scripted reconstruction: the development build itself is not running on this page.

Open the full demonstration →

Medication Reconciliation

Illustrative demonstration · intended workflow
Arrives
A discharge or clinic letter
Reedley prepares
Its instructions beside the medication list, each difference marked
The clinician decides
You accept, amend, query or leave each line
About Medication Reconciliation

Medication reconciliation

Synthetic patient

The clinician decides every row. Reedley lines the letter up with the record and prepares drafts for the clinician to check.

Doreen PICKERINGNHS 999 000 2002Born 2 Jul 1946 · 80 y · FemaleSnapshot 30 Oct 2026 09:20 · Calder Vale Medical Practice (fictional)

Step 1 of 4 · Letter beside the record

  1. Letter beside the record
  2. Differences in this letter
  3. Clinician reviews each row
  4. Handover summary
  • Letter Amlodipine 5 mg tablets · One dailyRecord Amlodipine 10 mg tablets · One dailyDose change
  • Letter Indapamide 2.5 mg tablets · StoppedRecord Indapamide 2.5 mg tablets · One each morningStopped
  • Letter Omeprazole 20 mg dispersible gastro-resistant tablets · One each morningRecord Omeprazole 20 mg gastro-resistant capsules · One each morningFormulation change
  • Letter Senna 7.5 mg tablets · Two at nightRecord Not on the medication recordNew
  • Letter Atorvastatin 20 mg tablets · One at nightRecord Atorvastatin 20 mg tablets · One at nightContinuing
  • Letter Levothyroxine 75 microgram tablets · One each morningRecord Levothyroxine 50 microgram tablets · One each morningStated two ways
  • Letter Aspirin 75 mg dispersible tablets · One dailyRecord Aspirin 75 mg dispersible tablets · Stopped 6 Mar 2026Conflict

Step 1 · Letter beside the record

Each medicine in the letter is placed beside the matching entry on the medication record.

Step 2 · Differences in this letter

Each row is labelled with the difference found in this letter: new, stopped, dose change, formulation change, continuing, or unclear or conflicting. Other letters can differ in other ways.

Step 3 · Clinician reviews each row

The visitor reviews as Priya DESAI, clinical pharmacist (synthetic): Accept proposal, Amend, No change or Query on each row; on the two conflicting rows, Query, Amend or No change only.

Record change the letter asks for, for the prescriber to decide: change amlodipine on the medication record from 10 mg to 5 mg once daily, as the letter states in ¶2 and the medicines table.

  • Accept proposalExample
  • Amend
  • No change
  • Query

Example decision for Priya DESAI, clinical pharmacist (synthetic). In the full demonstration you decide every row.

Step 4 · Handover summary

A handover summary lists every decision with its reason and source. Nothing is written to the record.

Amlodipine: proposal accepted by Priya DESAI, clinical pharmacist (synthetic). Change from 10 mg to 5 mg once daily assigned to the prescriber.

The prescriber updates the record in the clinical system. Reedley has not changed the medication record.

Illustrative demonstration · intended workflow · Scripted reconstruction: the development build itself is not running on this page.

Open the full demonstration →

Complex Medication Changes

Illustrative demonstration · intended workflow
Arrives
A specialist letter changing several medicines over weeks
Reedley prepares
Instructions, gaps and questions separated, and a clarification drafted
The clinician decides
A clinician confirms the plan before any dates or quantities
About Complex Medication Changes

Complex specialist letters and medication changes

Synthetic data

Step 1 of 4 · Gaps and conflicts flagged

  1. Gaps and conflicts flagged
  2. Checks in five states
  3. Dated two-track schedule
  4. Draft quantities

Step 1 · Gaps and conflicts flagged

State A Synthetic letter, real medicine names · Liam HARTLEY · NHS 999 000 2010

Prescription directions cannot yet be finalised.

Conflict

Lamotrigine: the letter and the record differ

  • The letter states lamotrigine 100 mg twice daily.The record has two lamotrigine repeat entries: 50 mg tablets, one twice daily, and 25 mg tablets, one twice daily.Clarification requiredReedley does not decide which dose is current.
  • Derived · Reedley’s reconstruction from the record, not stated in itThe two entries together come to 75 mg twice daily, if both are taken at each dose; this differs from the letter.

Step 2 · Checks in five states

State A Synthetic letter, real medicine names · Liam HARTLEY

Prescription directions cannot yet be finalised.

3 need clarification · 2 need clinician review · 1 evidence found.

  • Current lamotrigine doseClarification requiredUnresolved
  • Valproate reductionClarification requiredUnresolved
  • Lamotrigine increaseClarification requiredUnresolved
  • Interactions not checkedClinician review requiredReviewed by Dr H. MARSH (synthetic) · 28 Oct 15:10
  • ValproateClinician review requiredReviewed by Dr H. MARSH (synthetic) · 28 Oct 15:10
  • Specialist follow-upEvidence found

Reviewed appears only after a named clinician records it; Unresolved only when no reply is found by the chase date.

Step 3 · Dated two-track schedule

State B A separate plan with fictional medicines · not a completed version of the letter

Confirmed plan · Medicine A and Medicine B on one dated axis

Medicine A10 mg once dailyChanges on this date

Medicine B300 mg twice dailyChanges on this date

Show as a table
TrackFromToDose
Medicine A16 Nov 202622 Nov 202610 mg once daily
Medicine A23 Nov 202629 Nov 202610 mg twice daily
Medicine A30 Nov 20266 Dec 202620 mg twice daily
Medicine A7 Dec 202610 Jan 202740 mg twice daily
Medicine B16 Nov 202629 Nov 2026300 mg twice daily
Medicine B30 Nov 202613 Dec 2026200 mg twice daily
Medicine B14 Dec 202610 Jan 2027150 mg twice daily
Review point23 Nov 202629 Nov 2026Practice review
Review point7 Dec 202613 Dec 2026Practice review
Review point4 Jan 20278 Jan 2027Test X
Review point11 Jan 202711 Jan 2027Specialist review

Step 4 · Draft quantities

State B Fictional medicines · numbers chosen to show the arithmetic; not doses of any real medicine

Worked out by the demonstration’s deterministic calculator from the confirmed plan · Whole plan, 16 Nov 2026 to 10 Jan 2027 (56 days)

Medicine A 10 mg tablets

Medicine
Medicine A
Strength
10 mg
Form
tablet
  1. Take ONE tablet ONCE a day for 7 days (16 Nov 2026 to 22 Nov 2026)

    Dates 16 Nov 2026 to 22 Nov 2026Duration 7 daysFrequency Once a day

    Working 16 Nov 2026 to 22 Nov 2026: 7 days × 1 tablet × 1 dose a day = 7

  2. Take ONE tablet TWICE a day for 7 days (23 Nov 2026 to 29 Nov 2026)

    Dates 23 Nov 2026 to 29 Nov 2026Duration 7 daysFrequency Twice a day

    Working 23 Nov 2026 to 29 Nov 2026: 7 days × 1 tablet × 2 doses a day = 14

  3. Take TWO tablets TWICE a day for 7 days (30 Nov 2026 to 6 Dec 2026)

    Dates 30 Nov 2026 to 6 Dec 2026Duration 7 daysFrequency Twice a day

    Working 30 Nov 2026 to 6 Dec 2026: 7 days × 2 tablets × 2 doses a day = 28

Quantity49 tablets7 + 14 + 28 = 49

Illustrative demonstration · intended workflow · Scripted reconstruction: the development build itself is not running on this page.

Open the full demonstration →

See every demonstration

Medicines intelligence

Built around medicines.

Medication changes, shortages, requests and high-risk monitoring, laid out for the prescriber’s decision.

  1. Medication Reconciliation

    Illustrative demonstration · intended workflow
    ArrivesA discharge or clinic letterReedley preparesIts instructions beside the medication list, each difference markedThe clinician decidesYou accept, amend, query or leave each lineSee the capability
  2. Complex Medication Changes

    Illustrative demonstration · intended workflow
    ArrivesA specialist letter changing several medicines over weeksReedley preparesInstructions, gaps and questions separated, and a clarification draftedThe clinician decidesA clinician confirms the plan before any dates or quantitiesSee the capability
  3. Medicines Shortages

    Illustrative demonstration · intended workflow
    ArrivesA medicine in short supplyReedley preparesThe product and patient factors that matter, side by sideThe clinician decidesThe prescriber choosesSee the capability
  4. Prescription Request Triage

    In the development build · synthetic data
    ArrivesRepeat and one-off prescription requestsReedley preparesRequests grouped by what the record shows, each with a briefThe clinician decidesThe prescriber decides on every requestSee the capability
  5. Results, Monitoring and Recalls

    Illustrative demonstration · intended workflow
    ArrivesA medicine that needs blood testsReedley preparesEach result linked to its request and monitoring requirement; follow-up kept openThe clinician decidesA clinician reviews; follow-up is designed to close only when that review is recordedSee the capability
  6. Shared Care and High-Risk Medicines

    Illustrative demonstration · intended workflow
    ArrivesA specialist starts a high-risk medicine under shared careReedley preparesProtocol monitoring, responsibilities, latest results and outstanding actions togetherThe clinician decidesYour team actsSee the capability

Safety, governance and oversight

Clinicians decide. The evidence stays visible.

Six things a governance lead will ask about, each marked by where it stands today: a design commitment, work underway, or independently evidenced.

  • Human clinical review

    Every proposal is designed to wait for a named clinician to accept, edit or reject it. In the development build the review rules are enforced in Reedley’s own screens and the reviewer’s name is not yet a signed-in identity; enforcing the rules in the engine underneath is work underway.

    Clinical safety

    Status: work underway. Independently evidenced: not yet.

  • Evidence provenance

    Each finding, answer line and proposal links to the passage, entry or rule it came from, and the linked passage is shown word for word. This exists in the development build on synthetic letters; how reliably it holds on real correspondence has not been measured.

    Responsible AI

    Status: work underway. Independently evidenced: not yet.

  • Audit trail

    Who decided what, when and on which evidence is kept as an append-only history. In the development build it is held in development storage; a production store is planned and not built.

    Safety and governance

    Status: work underway. Independently evidenced: not yet.

  • Security controls

    Practice-level separation of patient data and role-based access are part of the design. In the development build they are enforced in Reedley’s screens only, there is no authenticated user, and no independent security test or certification has taken place.

    Security

    Status: design commitment. Independently evidenced: not yet.

  • Integration constraints

    Reedley is designed to work alongside clinical systems such as EMIS Web and SystmOne, and not to write to the medication record. Integration is not established on current evidence: the build runs against a simulated clinical system, and no supplier route has been applied for.

    Integrations

    Status: design commitment. Independently evidenced: not yet.

  • Clinical safety assurance

    An engineering draft of a DCB0129 hazard log exists. No Clinical Safety Officer has reviewed it, so it is not a safety case, and whether any part of Reedley is a medical device has not yet been assessed.

    Assurance register

    Status: work underway. Independently evidenced: not yet.

Nothing here is independently evidenced yet: every item in the assurance register is in progress, not applicable, not yet assessed or planned. Nothing on this site indicates certification, compliance or endorsement by the NHS or any other body.

For your role

Your role, your workflows.

Choose your role to see the workflows that matter most to you.

See it with your own work in mind.

Tell us your role and the workflows you care about, and we will walk you through them on synthetic data.